explore -WSS

explore

author：focus 2025-09-28 02:27:07 - browse：2

A yellow air ambulance in the sky. -- health business coverage from STAT — Ed Uthman

After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as to how health insurance companies and providers should settle their differences over how much to pay for out-of-network medical bills. Now, an air ambulance provider that already went through the arbitration process is suing Blue Cross Blue Shield of Arizona, which the company says won’t pay the agreed-upon amounts.

The idea behind the arbitration process is to protect patients from getting slapped with massive bills when providers and insurers can’t agree on how much a given health care service is worth. Instead of billing patients for the difference, the government established an independent dispute resolution process in which a third party picks between the provider’s and the payer’s offers for a claim.

This case is one of the first where the provider isn’t disputing the arbitration process itself, or the amount chosen. Instead, the air ambulance company, PHI Health, says BCBS of Arizona has failed to pay up after arbitration — even in cases where the arbitrator chose the amount the insurance company proposed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

entertainment

WSS

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Anthos stroke drug appears safer than common blood thinner

Boston Scientific acquires urology company Axonics for $3.7 billion

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Anthos stroke drug appears safer than common blood thinner

In key trial, Verve's treatment lowers cholesterol levels in patients

entertainment

explore

Wikipedia

Hollywood unions extend contract negotiations for actors

Anthos stroke drug appears safer than common blood thinner

Medicare details structure of new drug price negotiation program

Does Paxlovid work in people vaccinated against Covid

Drug repurposing or repositioning? The language matters

FDA early review: GLP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gain of function research would be limited under House proposal

Cancer drug shortages should be causing more outrage

Ascension's ugly legal battle over care for poor patients in Texas

entertainment

Anthos stroke drug appears safer than common blood thinner

Gain of function research would be limited under House proposal

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Boston Scientific acquires urology company Axonics for $3.7 billion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nonprofit, backed by Microsoft, to certify AI tools in health care

focus

entertainment

focus

hotspot